Manugistics GroupShares of the Rockville maker of supply-chain software dropped 7.9 percent yesterday after the company said it would swing to an unexpected loss in its latest quarter as software sales fell short of its targets. Manugistics said it expects a net loss of $7 million to $8 million, or 9 cents to 10 cents a share, for the fiscal first quarter that ended Monday. That would miss analysts' estimates by more than a dime a share.
The shares gained nearly 3 percent yesterday after the maker of stents for the treatment of heart problems, and other minimally invasive medical products, said it would acquire privately held Advanced Bionics Corp. for at least $740 million, giving the company a stronger presence in implanted microelectronic devices. A Boston Scientific official said the company could see $1 billion in sales by 2010 from the acquisition, which will expand Natick, Mass.-based Boston Scientific's business for the first time beyond catheter-based technologies.